An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.
from Latest Science News -- ScienceDaily https://ift.tt/3bKwEil
via IFTTT
Thursday, April 2, 2020
Trial drug can significantly block early stages of COVID-19 in engineered human tissues
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment